肺部超声在基层医疗中对COVID-19肺炎的早期诊断具有成本效益。
Lung ultrasound is cost-effective for early diagnosis of COVID-19 pneumonia in primary care.
作者信息
Martínez Redondo Javier, Comas Carles, Crespo Pons Montserrat, García Serrano Cristina, Pujol Salud Jesús, Casajuana Closas Marc, Ortega Bravo Marta, Palacín Peruga José María
机构信息
Balaguer Primary Care Center, Gerència Territorial Lleida, Catalan Health Institute (ICS) - Balaguer, Lleida, Spain.
Fundació Institut Universitari Per a La Recerca a L'Atenció Primària de Salut Jordi Gol I Gurina (IDIAPJGol), Barcelona, Spain.
出版信息
BMC Pulm Med. 2025 Jul 2;25(1):300. doi: 10.1186/s12890-025-03753-3.
Chest X-rays and lung ultrasounds are extensively utilized in primary care to diagnose pneumonia, a primary clinical manifestation of COVID-19. Employing chest X-rays for the diagnostic management of suspected COVID-19 pneumonia is significantly more costly than utilizing lung ultrasound. Since the pandemic swiftly overwhelmed healthcare systems globally, identifying the most cost-effective diagnostic tools is essential to optimize resource allocation.
胸部X光和肺部超声在初级医疗保健中被广泛用于诊断新冠肺炎的主要临床表现——肺炎。使用胸部X光对疑似新冠肺炎肺炎进行诊断管理的成本明显高于使用肺部超声。由于疫情迅速使全球医疗系统不堪重负，确定最具成本效益的诊断工具对于优化资源分配至关重要。
Zotero 插件